Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 18;39(2):58-71.
doi: 10.24272/j.issn.2095-8137.2017.012.

In vivo Genome Editing Thrives With Diversified CRISPR Technologies

Affiliations
Free PMC article
Review

In vivo Genome Editing Thrives With Diversified CRISPR Technologies

Xun Ma et al. Zool Res. .
Free PMC article

Abstract

Prokaryotic type II adaptive immune systems have been developed into the versatile CRISPR technology, which has been widely applied in site-specific genome editing and has revolutionized biomedical research due to its superior efficiency and flexibility. Recent studies have greatly diversified CRISPR technologies by coupling it with various DNA repair mechanisms and targeting strategies. These new advances have significantly expanded the generation of genetically modified animal models, either by including species in which targeted genetic modification could not be achieved previously, or through introducing complex genetic modifications that take multiple steps and cost years to achieve using traditional methods. Herein, we review the recent developments and applications of CRISPR-based technology in generating various animal models, and discuss the everlasting impact of this new progress on biomedical research.

Keywords: Animal models; CRISPR/Cas9; Genome editing.

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

See all similar articles

Cited by 2 articles

References

    1. Ablain J., Durand E.M., Yang S., Zhou Y., Zon L.I. A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish. Developmental Cell. 2015;32(6):756–764. doi: 10.1016/j.devcel.2015.01.032. - DOI - PMC - PubMed
    1. Aida T., Chiyo K., Usami T., Ishikubo H., Imahashi R., Wada Y., Tanaka K.F., Sakuma T., Yamamoto T., Tanaka K. Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice. Genome Biology. 2015;16:87. doi: 10.1186/s13059-015-0653-x. - DOI - PMC - PubMed
    1. Aida T., Nakade S., Sakuma T., Izu Y., Oishi A., Mochida K., Ishikubo H., Usami T., Aizawa H., Yamamoto T., Tanaka K. Gene cassette knock-in in mammalian cells and zygotes by enhanced MMEJ. BMC Genomics. 2016;17:979. doi: 10.1186/s12864-016-3331-9. - DOI - PMC - PubMed
    1. Anelli V., Villefranc J.A., Chhangawala S., Martinez-McFaline R., Riva E., Nguyen A., Verma A., Bareja R., Chen Z., Scognamiglio T., Elemento O., Houvras Y. Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression. ELife. 2017 doi: 10.7554/eLife.20728. - DOI - PMC - PubMed
    1. Auer T.O., Del Bene F. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish. Methods. 2014;69(2):142–150. doi: 10.1016/j.ymeth.2014.03.027. - DOI - PubMed

Grant support

This study was supported by funds provided by the Research Grants Council of Hong Kong (CUHK 14104614, TBF16ENG007 and TBF17MED002 to B.F.; and 3132966 to W.Y.C.), and in part by funds from the Croucher Foundation (CAS16CU01/ CAS16401 to W.Y.C.) and the National Basic Research Program of China (973 Program, 2015CB964700 to Y.L.)
Feedback